NO176144C - Nye difosfonsyreforbindelser - Google Patents

Nye difosfonsyreforbindelser

Info

Publication number
NO176144C
NO176144C NO922565A NO922565A NO176144C NO 176144 C NO176144 C NO 176144C NO 922565 A NO922565 A NO 922565A NO 922565 A NO922565 A NO 922565A NO 176144 C NO176144 C NO 176144C
Authority
NO
Norway
Prior art keywords
present
acid compounds
diphosphonic acid
relates
novel compounds
Prior art date
Application number
NO922565A
Other languages
English (en)
Other versions
NO176144B (no
NO922565D0 (no
NO922565L (no
Inventor
Frank Hallock Ebetino
Kent Warren Buckingham
Jocelyn Elaine Mcosker
Original Assignee
Procter & Gamble Pharma
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO922565L publication Critical patent/NO922565L/no
Application filed by Procter & Gamble Pharma, Norwich Eaton Pharma filed Critical Procter & Gamble Pharma
Priority to NO922565A priority Critical patent/NO176144C/no
Publication of NO922565D0 publication Critical patent/NO922565D0/no
Publication of NO176144B publication Critical patent/NO176144B/no
Publication of NO176144C publication Critical patent/NO176144C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/5765Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paints Or Removers (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO922565A 1986-12-19 1992-06-29 Nye difosfonsyreforbindelser NO176144C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO922565A NO176144C (no) 1986-12-19 1992-06-29 Nye difosfonsyreforbindelser

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/945,069 US4868164A (en) 1986-12-19 1986-12-19 Octahydro-pyridine diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
NO875305A NO174625C (no) 1986-12-19 1987-12-18 Analogifremgangsmåte for fremstilling av terapeutisk aktiv cis-oktahydro-1-pyrindin-6,6-difosfonsyre
NO922565A NO176144C (no) 1986-12-19 1992-06-29 Nye difosfonsyreforbindelser

Publications (4)

Publication Number Publication Date
NO922565L NO922565L (no) 1988-06-20
NO922565D0 NO922565D0 (no) 1992-06-29
NO176144B NO176144B (no) 1994-10-31
NO176144C true NO176144C (no) 1995-02-08

Family

ID=25482572

Family Applications (2)

Application Number Title Priority Date Filing Date
NO875305A NO174625C (no) 1986-12-19 1987-12-18 Analogifremgangsmåte for fremstilling av terapeutisk aktiv cis-oktahydro-1-pyrindin-6,6-difosfonsyre
NO922565A NO176144C (no) 1986-12-19 1992-06-29 Nye difosfonsyreforbindelser

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO875305A NO174625C (no) 1986-12-19 1987-12-18 Analogifremgangsmåte for fremstilling av terapeutisk aktiv cis-oktahydro-1-pyrindin-6,6-difosfonsyre

Country Status (18)

Country Link
US (3) US4868164A (no)
EP (1) EP0273514B1 (no)
JP (1) JP2573973B2 (no)
KR (1) KR950009196B1 (no)
AT (1) ATE59046T1 (no)
AU (1) AU615886B2 (no)
CA (1) CA1321793C (no)
DE (1) DE3766695D1 (no)
DK (1) DK171068B1 (no)
FI (1) FI87652C (no)
HK (1) HK79393A (no)
IE (1) IE873456L (no)
IL (1) IL84660A (no)
MY (1) MY102266A (no)
NO (2) NO174625C (no)
NZ (1) NZ222985A (no)
PH (1) PH25583A (no)
ZA (1) ZA879502B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868164A (en) * 1986-12-19 1989-09-19 Norwich Eaton Pharmaceuticals, Inc. Octahydro-pyridine diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
IL86951A (en) * 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
DE3822650A1 (de) * 1988-07-05 1990-02-01 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US5753634A (en) * 1992-05-29 1998-05-19 The Procter & Gamble Company Quaternary nitrogen containing phosphonate compounds, pharmaceutical compostions, and methods for treating abnormal calcium and phosphate metabolism
RU2126414C1 (ru) * 1992-05-29 1999-02-20 Дзе Проктер энд Гэмбл Фармасьютикалз, Инк. Содержащие четвертичный азот фосфонаты для лечения анормального кальциевого и фосфатного метаболизма, а также профилактики и лечения зубных налетов и зубных камней, фармацевтические композиции и способ лечения
US5391743A (en) * 1992-05-29 1995-02-21 Procter & Gamble Pharmaceuticals, Inc. Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque
SK144694A3 (en) * 1992-05-29 1995-06-07 Procter & Gamble Pharma Thio-substituted nitrogen containing heterocyclic phosphate compounds for treating calcium and phosphate metabolism
NZ253524A (en) * 1992-05-29 1997-01-29 Procter & Gamble Pharma Sulphur-containing phosphonate derivatives and medicaments (for treating abnormal calcium and phosphate metabolism)
US5763611A (en) * 1992-05-29 1998-06-09 The Procter & Gamble Company Thio-substituted cyclic phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
AU675796B2 (en) * 1992-06-30 1997-02-20 Procter & Gamble Pharmaceuticals, Inc. Compositions for the treatment of arthritis containing phosphonates and NSAIDS
EP0779812A4 (en) * 1994-09-09 1997-09-10 Procter & Gamble METHOD FOR TREATING OSTEOPOROSIS USING BONE-ACTIVE PHOSPHONATES AND PARATHORMONE
EP0753523A1 (en) 1995-07-10 1997-01-15 Gador S.A. Amino-substituted bisphosphonic acids
US7781418B2 (en) * 2006-12-14 2010-08-24 Isis Innovation Ltd. Composition for treating bone disorders
US11793452B2 (en) 2019-10-03 2023-10-24 Johnson & Johnson Consumer Inc. Method of visualizing and quantifying remineralization

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3553314A (en) * 1968-12-23 1971-01-05 Procter & Gamble Oral compositions for calculus retardation
DE1958123C3 (de) * 1969-11-19 1978-09-28 Henkel Kgaa, 4000 Duesseldorf Verfahren zur Herstellung von 1 -Aminoalkan-1,1 -diphosphonsäuren oder deren Salzen
US3979385A (en) * 1969-11-19 1976-09-07 Henkel & Cie G.M.B.H. 1-Aminoalkane-1,1-diphosphonic acids and their salts
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3899496A (en) * 1970-10-06 1975-08-12 Henkel & Cie Gmbh Production of 1-aminoalkane-1,1-diphosphonic acids
DE2104476C2 (de) * 1971-02-01 1983-12-01 Henkel KGaA, 4000 Düsseldorf Verfahren zur Verhinderung von Ausfällungen in Wasser oder wäßrigen Lösungen
US3988443A (en) * 1973-08-27 1976-10-26 Henkel & Cie G.M.B.H. Azacycloalkane-2,2-diphosphonic acids
DE2343147C2 (de) * 1973-08-27 1982-06-09 Henkel KGaA, 4000 Düsseldorf Pyrrolidon-5,5-diphosphonsäuren, deren wasserlösliche Salze, und Verfahren zu ihrer Herstellung
DE2343196C3 (de) * 1973-08-27 1980-01-10 Henkel Kgaa, 4000 Duesseldorf Aiacycloalkan-2^-diphosphonsäuren oder deren wasserlösliche Salze
US4034086A (en) * 1973-08-27 1977-07-05 Henkel & Cie G.M.B.H. Pyrrolidone-5,5-diphosphonic acids
DE2456666A1 (de) * 1974-11-30 1976-08-12 Henkel & Cie Gmbh Verfahren zum stabilisieren von calcium-hydrogenphosphat-dihydrat gegen hydrolyse
DE2543349C2 (de) * 1975-09-29 1984-05-10 Henkel KGaA, 4000 Düsseldorf Preaparate zur herstellung von99m technetium-radiagnostica
SE7612534L (sv) * 1975-12-01 1977-06-02 Henkel & Cie Gmbh Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning
DE2745083C2 (de) * 1977-10-07 1985-05-02 Henkel KGaA, 4000 Düsseldorf Hydroxydiphosphonsäuren und Verfahren zu deren Herstellung
US4230700A (en) * 1977-12-07 1980-10-28 The Procter & Gamble Company Methods for inhibiting mobilization of calcium phosphate in animal tissue
SU1002300A1 (ru) * 1981-10-29 1983-03-07 Ордена Ленина институт элементоорганических соединений им.А.Н.Несмеянова Способ получени @ -аминозамещенных- @ -оксипропилидендифосфоновых кислот
DE3428524A1 (de) * 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4687768A (en) * 1984-12-21 1987-08-18 The Procter & Gamble Company Certain hexahydroindan-2,2-diphosphonic acids useful in treating diseases associated with abnormal calcium and phosphate metabolism
DE3540150A1 (de) * 1985-11-13 1987-05-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4868164A (en) * 1986-12-19 1989-09-19 Norwich Eaton Pharmaceuticals, Inc. Octahydro-pyridine diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism

Also Published As

Publication number Publication date
NO174625C (no) 1994-06-08
NO176144B (no) 1994-10-31
DK171068B1 (da) 1996-05-20
US5393746A (en) 1995-02-28
IL84660A0 (en) 1988-04-29
JP2573973B2 (ja) 1997-01-22
NO922565D0 (no) 1992-06-29
NO875305L (no) 1988-06-20
DK670387D0 (da) 1987-12-18
DE3766695D1 (de) 1991-01-24
DK670387A (da) 1988-06-20
CA1321793C (en) 1993-08-31
PH25583A (en) 1991-08-08
EP0273514B1 (en) 1990-12-12
FI87652B (fi) 1992-10-30
FI875595A0 (fi) 1987-12-18
EP0273514A1 (en) 1988-07-06
ZA879502B (en) 1988-06-16
ATE59046T1 (de) 1990-12-15
HK79393A (en) 1993-08-13
NO922565L (no) 1988-06-20
IL84660A (en) 1994-10-21
FI875595A (fi) 1988-06-20
AU8280987A (en) 1988-06-23
US5137880A (en) 1992-08-11
US4868164A (en) 1989-09-19
AU615886B2 (en) 1991-10-17
IE873456L (en) 1988-06-19
MY102266A (en) 1992-05-15
FI87652C (fi) 1993-02-10
JPS63239290A (ja) 1988-10-05
NO174625B (no) 1994-02-28
NO875305D0 (no) 1987-12-18
KR880007473A (ko) 1988-08-27
NZ222985A (en) 1990-09-26
KR950009196B1 (ko) 1995-08-16

Similar Documents

Publication Publication Date Title
PH25769A (en) Certain cycloalkane-1,1-diphosphonic acids, derivatives thereof having the ability to treat diseases associated with abnormal calcium, phosphate metabolism
LU90669I2 (fr) Actonel
DK375588A (da) Methylenphosphonalkylphosphinsyreforbindelser og farmaceutiske sammensaetninger indeholdende samme
NO176144C (no) Nye difosfonsyreforbindelser

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees